Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trialBruno François, Alain Lepape, Philippe Eggimann et al.|The Lancet Infectious Diseases|2021Cited by 88
Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trialChristopher Adlbrecht, Jordi Rello, Raphael Wurm et al.|Critical Care|2020Cited by 83